US 6,982,153 B1 | ||
DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides | ||
Jerry Pelletier, Baie-d'Urfe (Canada); Philippe Gros, St. Lambert (Canada); and Michael DuBow, Montreal (Canada) | ||
Assigned to Targanta Therapeutics, Inc., St. Laurent (Canada) | ||
Filed on Sep. 28, 1999, as Appl. No. 9/407,804. | ||
Claims priority of provisional application 60/110992, filed on Dec. 03, 1998. | ||
Int. Cl. C12P 21/02 (2006.01); C07H 21/04 (2006.01) |
U.S. Cl. 435—69.1 | 16 Claims |
1. An isolated, purified, or enriched nucleic acid sequence at least 90 nucleotides in length, wherein said sequence is at least 95% identical to a Staphylococcus aureus bacteriophage 77 open reading frame (ORF) selected from the group consisting of ORF 17 (SEQ ID NO: 4), ORF 19 (SEQ ID NO: 5), ORF 43 (SEQ ID NO: 6), ORF 102 (SEQ ID NO: 7), ORF 104 (SEQ ID NO: 8), and ORF 182 (SEQ ID NO: 9). |